“…Most of these studies reported using nanomaterials or a combination of nanomaterials and composites, mainly due to their large surface area and good biocompatibility, which enhanced the analytical performance of these biosensors [87]. For example, Ibupoto et al [84], Zhou et al [87] and Justino et al [88] ZnO nanotubes, Fe3O4-SiO2 magnetic nanoprobes and SWCNTs as labels to immobilize antibodies in immunosensors for CRP detection. At levels exceeding 3 mg L −1 , CRP, an acute-phase protein, is used to evaluate the risk of developing CVDs such as atherosclerosis, angina, coronary heart disease, peripheral artery disease, myocardial infarction and stroke.…”